Lighthouse Investment Partners’s ResMed RMD Stock Holding History

Lighthouse Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,500	Closed	-$3.66M	–	518
2024 Q1	$3.66M	Buy	+18,500	New	+$3.39M	0.17%	163

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Lighthouse Investment Partners's RMD Position: Q3 2025 in Review

Lighthouse Investment Partners sold out of ResMed (RMD) in Q3 2025, closing a stake of 800 shares — an estimated $206K sold.

Lighthouse Investment Partners first reported a position in RMD in Q1 2024 and held it in 3 quarters. The position peaked at $4.75M in Q3 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Lighthouse Investment Partners reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Lighthouse Investment Partners sold 800 ResMed shares in Q3 2025, an estimated $206K.
Lighthouse Investment Partners first reported a position in ResMed in Q1 2024 and held it in 3 quarters.
Lighthouse Investment Partners's ResMed position peaked at $4.75M in Q3 2024.
950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Lighthouse Investment Partners's 13F filing for Q3 2025, filed 14 Nov 2025.